期刊文献+

手术联合抗肿瘤坏死因子α制剂治疗克罗恩病合并肛瘘临床疗效的Meta分析 被引量:4

Clinical efficacy of surgery combined with anti-TNF-alpha in treatment of Crohn's disease with perianal fistulas: a Meta analysis
原文传递
导出
摘要 目的系统评价手术联合抗肿瘤坏死因子仪(TNF-α)制剂治疗克罗恩病合并肛瘘患者的临床疗效。方法以Crohn’s disease、anal fistula、fistula、perianal fistula、surgicalprocedure、surgery、surgical、antitumour necrosis factor-alpha、anti-TNF-alpha、TNF—alpha、克罗恩病、Crohn’s病、肛瘘、手术治疗、外科手术、抗肿瘤坏死因子IX制剂、肿瘤坏死因子、肿瘤坏死因子配体超家族成员2为检索词,检索中国生物医学文献数据库,万方数据库、PubMed、Cochrane Library、EMBASE数据库。检索期限为建库至2016年6月。纳入手术联合TNF—IX制剂对比单纯手术治疗克罗恩病合并肛瘘患者的回顾性病例对照研究。由2名研究者独立行筛选文献和数据提取,并进行文献质量评价。采用手术联合TNF—IX制剂治疗的患者设为联合治疗组,单纯手术治疗的患者设为手术组。比较两组患者的完全愈合率、部分愈合率及治疗复发率。计数资料采用优势比(OR)及95%可信区间(95%CI)表示。采用,2对异质性进行分析。结果最终共6篇文献纳入研究,均为回顾性病例对照研究,累计样本量598例,其中联合治疗组256例,手术组342例。Meta分析结果显示:联合治疗组与手术组克罗恩病合并肛瘘患者的完全愈合率、部分愈合率比较,差异均无统计学意义(OR=1.36,1.47,95%CI:0.94~1.97,0.56—3.88,P〉0.05)。联合治疗组克罗恩病合并肛瘘患者的治疗复发率低于手术组,差异有统计学意义(OR=0.26,95%CI:0.16~0.44,P〈0.05)。结论手术联合抗TNF-α制剂治疗克罗恩病合并肛瘘,其完全愈合率和部分愈合率并未优于单纯手术治疗,但治疗复发率低于单纯手术治疗。 Objective To evaluate systematically the clinical efficacy of surgery combined with anti-TNF- alpha in treatment of Crohn's disease (CD) with perianal fistula. Method Database including China Biology Medicine disc, Wan Fang Database, PubMed, Cochrane Library and EMBASE were searched with " Crohn's disease, anal fistula, fistula, perianal fistula, surgical procedure, surgery, surgical, anti-tumor necrosis factor- alpha, anti-TNF-alpha, TNF-alpha,克罗恩病,Crohn's病,肛瘘,手术治疗,外科手术,抗肿瘤坏死因子α制剂,肿瘤坏死因子,肿瘤坏死因子配体超家族员2" between the database establishment and June 2016. Literatures of retrospective case-control studies about surgery combined with anti-TNF-alpha therapy and single surgery in treatment of CD with perianal fistula were retrieved. Data were extracted and evaluated by 2 independent researchers. Patients who underwent surgery combined with anti-TNF-alpha therapy were allocated into the combined therapy group and patients who underwent single surgical treatment were allocated into the surgery group. The complete healing rate, partial healing rate and recurrence rate after therapy were compared between the 2 groups. Count data were represented as the odds ratio (OR) and 95% confidence interval (CI). The heterogeneity was analyzed by the 12 test. Result Six retrospective case-control studies were retrieved and total sample size was 598 patients, including 256 in the combined therapy group and 342 in the surgery group. The result of Meta analysis showed that there was no significant difference in postoperative complete healing rate and partial healing rate between the 2 groups ( OR = 1.36, 1.47, 95 % CI:0. 94-1.97, 0. 56-3.88, P 〉 0.05), and recurrence rate after therapy in the combined therapy group was significantly lower than that in the surgery group (OR = 0. 26, 95 % CI: 0. 16-0. 44, P 〈 0.05). Conclusion The complete healing rate and partial healing rate of patients with CD with perianal fistula u
出处 《中华消化外科杂志》 CAS CSCD 北大核心 2016年第12期1176-1181,共6页 Chinese Journal of Digestive Surgery
基金 天津市卫生与计划生育委员会科技基金(2010KZ114)
关键词 克罗恩病 肛瘘 外科手术 抗肿瘤坏死因子Α META分析 Crohn's disease Perianal fistula Surgical procedures, operative Anti-TNF-ct Meta analysis
  • 相关文献

参考文献5

二级参考文献78

  • 1Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340:1398-405. 被引量:1
  • 2Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Inflix- imab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004; 350:876-885. 被引量:1
  • 3Spradlin NM, Wise PE, Herline AJ, Muldoon RL, Rosen M, Schwartz DA. A randomized prospective triaI of endoscopic ultrasound to guide combination medical and surgical treat- ment for Crohn's perianal fistulas. Am J Gastroenterol 2008; 103:2527-2535. 被引量:1
  • 4Gaertner WB, Decanini A, Mellgren A, Lowry AC, Gold- berg SM, Madoff RD, Spencer MP. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis Colon Rectum 2007; 50:1754-1760. 被引量:1
  • 5Hyder SA, Travis SP, Jewell DP, McC Mortensen NJ, George BD. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum 2006; 49: 1837-1841. 被引量:1
  • 6Irvine EJ. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J CIin Gastroenterol 1995; 20:27-32. 被引量:1
  • 7Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg 1976; 63:1-12. 被引量:1
  • 8Present DH. Crohn's fistula: current concepts in manage- ment. Gastroenterology 2003; 124:1629-1635. 被引量:1
  • 9Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with metronidazole. Gastroenterol- ogy 1980; 79:357-365. 被引量:1
  • 10O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gas- troenterology 1991; 101:3946. 被引量:1

共引文献31

同被引文献38

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部